On the fly News and insights, exclusive to thefly.com

FATE

Fate Therapeutics

$91.35 /

+5.245 (+6.09%)

, CALT

Calliditas Therapeutics

$29.73 /

+1.42 (+5.02%)

09:54
02/26/21
02/26
09:54
02/26/21
09:54

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Fate Therapeutics (FATE) initiated with a Buy at BofA. 2. Calliditas Therapeutics (CALT) initiated with a Buy at H.C. Wainwright. 3. Personalis (PSNL) assumed with a Buy at Needham. 4. Trxade Group (MEDS) initiated with a Buy at Maxim. 5. Amyris (AMRS) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

FATE

Fate Therapeutics

$91.35 /

+5.245 (+6.09%)

CALT

Calliditas Therapeutics

$29.73 /

+1.42 (+5.02%)

PSNL

Personalis

$30.99 /

-0.705 (-2.22%)

MEDS

Trxade Group

$6.33 /

-0.07 (-1.09%)

AMRS

Amyris

$14.92 /

+1.05 (+7.57%)

  • 01

    Mar

  • 02

    Mar

  • 10

    Mar

  • 15

    Mar

  • 05

    Jun

  • 09

    Jun

  • 12

    Aug

  • 06

    Jan

  • 27

    Jan

  • 29

    Jan

FATE Fate Therapeutics
$91.35 /

+5.245 (+6.09%)

02/26/21
Fly Intel: Top five analyst downgrades
02/26/21 Truist
Fate Therapeutics price target raised to $135 from $85 at Truist
02/26/21 Wedbush
Fate Therapeutics downgraded to Neutral from Outperform at Wedbush
02/26/21 BofA
BofA starts Fate Therapeutics at Buy with $115 price target
CALT Calliditas Therapeutics
$29.73 /

+1.42 (+5.02%)

02/26/21 H.C. Wainwright
Calliditas Therapeutics initiated with a Buy at H.C. Wainwright
07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
PSNL Personalis
$30.99 /

-0.705 (-2.22%)

02/26/21 Needham
Personalis assumed with a Buy at Needham
01/27/21 Truist
Personalis initiated with a Buy at Truist
01/04/21 BofA
Personalis downgraded to Neutral on valuation at BofA
01/04/21 BofA
Personalis downgraded to Neutral from Buy at BofA
MEDS Trxade Group
$6.33 /

-0.07 (-1.09%)

02/26/21 Maxim
Trxade Group initiated with a Buy at Maxim
12/03/20 National Securities
Trxade Group initiated with a Buy at National Securities
AMRS Amyris
$14.92 /

+1.05 (+7.57%)

02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
01/06/21 Cowen
Amyris upgraded to Outperform with $9 price target at Cowen
01/06/21 Cowen
Amyris upgraded to Outperform from Market Perform at Cowen
11/25/20
Fly Intel: Top five analyst initiations

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.